Voxeljet AG (ADR) (NYSE:VJET) announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2013 with the Securities and Exchange Commission on March 27, 2014. Voxeljet AG (ADR) (NYSE:VJET) shares after opening at $15.93 on last trade day and at the end of the day closed at $15.10. Company price to sales ratio in past twelve months was calculated as 21.39 and price to cash ratio as 500.41. Voxeljet AG (ADR) (NYSE:VJET) showed a negative weekly performance of -39.70%.
Halozyme Therapeutics (NASDAQ:HALO)‘s stock had its “buy” rating restated by BMO Capital Markets in a research note issued on Friday, AnalystRatings.NET reports. Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares fell -0.93% in last trading session and ended the day on $7.42. HALO return on assets ratio is recorded as -76.60%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) yearly performance is 24.29%.
On April 8, NewLead Holdings Ltd (NASDAQ:NEWL) announced that it has previously signed a term sheet with a leading financial institution to provide 75% debt financing for two second-hand Panamax vessels for a total of $35M. The two vessels are expected to be delivered to NewLead’s fleet within the next three months, subject to the receipt of the necessary financing for the balance of the purchase price. NewLead Holdings Ltd (NASDAQ:NEWL) shares moved down -17.48% in last trading session and was closed at $0.462, while trading in range of $0.46 – $0.56. NewLead Holdings Ltd (NASDAQ:NEWL) year to date (YTD) performance is -97.39%.
Datawatch Corporation (NASDAQ:DWCH) announced after the close Thursday that it expects second quarter revenues to be between $7.8 and $8.0 million and non-GAAP net loss between $3.1 million and $3.3 million. This compares to total revenue of $6.83 million and non-GAAP net income of $389,000 last year. Datawatch Corporation (NASDAQ:DWCH) weekly performance is -40.44%. On last trading day company shares ended up $14.67. Datawatch Corporation (NASDAQ:DWCH) distance from 50-day simple moving average (SMA50) is -49.72%. Analysts mean target price for the company is $38.75.